In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.
Commentary|Podcasts|April 25, 2025
Fast-Tracking the Future
Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.
Advertisement
In this exclusive PC Podcast interview, Claire Riches, vice president of clinical solutions at Citeline, dives into:
- Specific inefficiencies in the current drug approval system that are the biggest obstacles to faster approvals
- How the FDA can integrate data sources such as real-world data (RWD) to streamline approvals, while maintaining rigorous safety standards
- Advancements in data collection and validation that make RWD a viable tool for drug approvals
- The role payers and insurers should play in this shift toward a more data-driven, flexible approval framework, and how this could impact patient access to innovative treatments
- The likelihood of bipartisan support for reforms that modernize drug approvals with shifting political priorities under HHS Secretary Robert F. Kennedy Jr.
Advertisement
Related to this article
In this week's Pharma Pulse, DHL adds six dedicated cold chain air corridors linking Europe and North America to Asia, Walmart rolls out a $0 prescription tier and rare disease Center of Excellence for its US workforce and FDA launches its Rare Disease Framework Initiative.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Episode 4 of Supply Chain Signal examines PhRMA’s legal challenge to CMS’ GLOBE model and whether manufacturers can lower costs, expand U.S. production and strengthen supply chain resilience all at once.
With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
PAXAFE's Mark Talens explains why real-time visibility starts with process redesign and how it speeds cold chain disposition decisions.
FDA’s final guidance on prescription drug use-related software clarifies when companion app content is labeling, promotion or belongs in the PI.
Epic's Prescription Marketplace, due summer 2027, will show pharmacy cash prices next to insured costs before a prescription is sent.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Pharma Automation Cuts Human Touches and Error Risk
2
Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion
3
Is Pharma Moving Too Fast on AI Agents?
4
Inside the 340B Rebate Pilot Standoff: Court, Congress, Drugmakers
5